The Board of Directors of Square Pharmaceuticals PLC. has recommended 105% Cash Dividend for the year ended June 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
210.9 BDT | +1.39% | -0.85% | +0.29% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.29% | 1.7B | |
+29.68% | 681B | |
+21.26% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+13.58% | 235B | |
+4.52% | 199B | |
-12.35% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- SQURPHARMA Stock
- News Square Pharmaceuticals PLC.
- Square Pharmaceuticals PLC. Recommends Cash Dividend for the Year Ended June 30, 2023